查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球临床前影像市场
市场调查报告书
商品编码
1380448

2023-2030 年全球临床前影像市场

Global Preclinical Imaging Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

全球临床前影像市场预计在预测期（2023-2030年）CAGR为6.82%。市场的成长归因于灵敏度和分辨率的提高。高场 MRI 系统提高了扫描的灵敏度和分辨率，使研究人员能够检测和分析动物模型中微妙的结构和功能修饰。这种更高水平的灵敏度和分辨率对于准确建模疾病和评估潜在候选药物非常重要。因此，市场参与者正在推出新产品来满足新 MRI 设备的需求。例如，2022年5月，布鲁克推出了创新的磁振造影（MRI）设备，包括7.4特斯拉和9.4特斯拉传导冷却麦克斯韦磁体，构成其市场领先的临床前MRI系统产品线的组成部分。 BioSpec Maxwell 3 Tesla 模型取得了巨大成功，由于新一代 Maxwell 7.4 Tesla 和 9.4 Tesla 磁铁，液体不再是必需品。同时为创新的 PET/MR 和 MRI 临床前研究提供高场灵敏度和氮气或氦气填充解析度。

细分市场前景

全球临床前成像市场按产品、应用和最终用户进行细分。根据产品，市场细分为 MicroCT、MRI、PET、超音波成像、光学成像、光声成像等。根据应用，市场细分为製药和生物技术公司、研发、神经病学和神经科学等。此外，根据最终用户，市场细分为製药和生物技术公司、学术和研究机构、医院和医疗中心、政府研究机构等。该製药和生物技术公司的子类别预计将占据最终用户细分市场的很大一部分市场份额。这是由于传染病的发展和重新出现、对临床前成像的需求以增强对病原体的理解并鼓励创新疗法和疫苗的创造。

预计超音波成像细分市场将在全球临床前成像市场中占据相当大的份额

其中，超音波成像细分市场预计将在全球临床前成像市场中占据相当大的份额。细分市场的成长归因于技术的创新。由于超音波和光声成像等成像技术的进步，研究人员能够探索新的临床前研究方向，从而导致使用量的增加。因此，市场参与者正在推出新产品，以满足临床前使用超音波和光声成像系统的需求。例如，2022年5月，FUJIFILM VisualSonics Inc.推出了全球首款临床前使用的超高低频（71MHz-1MHz）超音波和光声成像系统Vevo F2。 Vevo F2 产生从感测器到显示器的全新讯号管道，并包含高清影像处理技术。与多线处理相结合，它提高了影像清晰度，并导致比前几代平台显着更高的帧速率。

区域展望

全球临床前影像市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，预计亚太地区将在全球市场中占据显着份额，因为由于政府加大对各国研发部门成长的支持，该地区越来越需要临床前研究。

北美地区预计全球临床前影像市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域增长归因于该地区医疗保健的扩张。随着医疗保健服务的成长，全球对先进影像技术（尤其是临床前影像）的需求预计将增加。根据美国劳工统计局的数据，2023 年 9 月，放射线和 MRI 技术人员的总就业人数预计在 2022 年至 2032 年间将成长 6%，快于所有职业的平均水准。未来十年，预计放射学和 MRI 技术人员的职缺平均为 15,700 个。预计替换因退休而改变职业或离开劳动力队伍的工人的需求将导致大部分可用职位空缺。

市场参与者展望

服务全球临床前影像市场的主要公司包括： Bruker Corp.、Euro-BioImaging ERIC、FUJIFILM Holdings Corp.、IVIM Technology Corp.、Mediso Kft.。和别的。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2019年5月，布鲁克不断合作开发了第一台18特斯拉、11公分孔径、临床前超高场（UHF）MRI机器。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球临床前成像市场运营的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Advanced Molecular Vision, Inc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Aspect Imaging Ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • AXT PTY LTD.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品分類的全球临床前影像市场
    • MicroCT（微型电脑断层扫描）
    • MRI（磁振造影）
    • PET（正子断层扫描）
    • 超音波成像
    • 光学成像
    • 光声成像
    • 其他（放射性药物和示踪剂，以及红外线成像）
  • 全球临床前影像市场（按应用）
    • 研究与开发
    • 神经病学和神经科学
    • 其他（毒理学和安全性评估、基因治疗和分子影像、精准医疗、个人化治疗）
  • 按最终用户分類的全球临床前影像市场
    • 製药和生物技术公司
    • 学术研究机构
    • 医院和医疗中心
    • 政府研究机构
    • 其他（药理学和毒理学实验室以及监管机构和当局）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Bruker Corp.
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings Corp.
  • IVIM Technology Corp.
  • Mediso Kft.
  • MR Solutions Ltd.
  • Oxford Nanoimaging Ltd.
  • PerkinElmer AES
  • Photon Etc. Inc
  • Revvity, Inc.
  • Shanghai United Imaging Healthcare Co., LTD.
Product Code: OMR2027737

Title: Global Preclinical Imaging Market Size, Share & Trends Analysis Report by Product (MicroCT (Micro Computed Tomography), MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), Ultrasound Imaging, Optical Imaging, Photoacoustic Imaging, and Others), by Application (Pharma and Biotech Companies, Research and Development, Neurology and Neuroscience, and Others), and by End-User (Pharma and Biotech Companies, Academic and Research Institutions, Hospitals and Medical Centers, Government Research Agencies, and Others)Forecast Period (2023-2030).

The global preclinical imaging market is anticipated to grow at a CAGR of 6.82% during the Forecast Period (2023-2030). The market's growth is attributed to enhancement of sensitivity and resolution. High-field MRI systems improve the sensitivity and resolution of scans, enabling researchers to detect and analyze delicate structural and functional modifications in animal models. This higher level of sensitivity and resolution is important for accurately modeling diseases and evaluating potential drug candidates. Accordingly market players are coming up with new products to cater the demand for new MRI devices. For instance, in May 2022,Bruker launched innovative magnetic resonance imaging (MRI) devices, including 7.4 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets, form a component of its product line of market-leading preclinical MRI systems. The BioSpec Maxwell 3 Tesla model was an enormous success, and the Liquid is ceased to essential owing to a new generation of Maxwell 7.4 Tesla and 9.4 Tesla magnets. while providing high-field sensitivity and nitrogen or helium refills resolution for innovative PET/MR and MRI preclinical research.

Segmental Outlook

The global preclinical imaging market is segmented on the product, application, and end-user. Based on the product, the market is sub-segmented into MicroCT, MRI, PET, ultrasound imaging, optical imaging, photoacoustic imaging, and others. Based on the application, the market is sub-segmented into pharma and biotech companies, research and development, neurology and neuroscience, and others. Furthermore, on the basis of end-user, the market is sub-segmented into pharma and biotech companies, academic and research institutions, hospitals and medical centers, government research agencies, and others. The pharma and biotech company's subcategory is expected to capture a significant portion of the market share within the end-user segment. This is attributed to the development and reemergence of infectious diseases, the demand for preclinical imaging for enhanced comprehension of pathogens and encourage the creation of innovative therapies and vaccines.

The Ultrasound Imaging Sub-Segment is Anticipated to Hold a Considerable Share of the Global Preclinical Imaging Market

Among the product, the ultrasound imaging sub-segment is expected to hold a considerable share of the global preclinical imaging market. The segmental growth is attributed to the innovation in technology. Increased usage results from the ability of researchers to explore new preclinical research directions owing to advancements in imaging technologies such as ultrasound and photoacoustic imaging. Accordingly market players are coming up with new products to cater the demand for ultrasound and photoacoustic imaging system designed for preclinical use. For instance, in May 2022,FUJIFILM VisualSonics Inc., launched Vevo F2, the globe's first ultra-high to low frequency (71MHz-1MHz) ultrasound and photoacoustic imaging system for preclinical use. The Vevo F2 produces entire new signal pipeline, from transducer to display screen, and includes HD image processing technologies. In combination with multi-line processing, it improves image clarity and results in significantly higher frame rates than platforms from preceding generations.

Regional Outlook

The global preclinical imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, as the region has grown increasingly desirable for preclinical research studies owing to increased government support for the growth of the research and development sector in the individual countries.

The North America Region is Expected to Grow at a Significant CAGR in the Global Preclinical Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the expansion of healthcare in the region. Global demand for advanced imaging technologies, especially preclinical imaging, is anticipated to increase as healthcare services grow. According to the US Bureau of Labor Statistics, in September 2023, Radiologic and MRI technologists' total employment is anticipated to increase by 6% between 2022 and 2032, faster than the average for all occupations. Over the next ten years, there are anticipated to be, on average, 15,700 openings for radiologic and MRI technologists. The need to replace workers that change careers or leave the workforce owing to retirement is predicted to cause a large portion of the available openings.

Market Players Outlook

The major companies serving the global preclinical imaging market include: Bruker Corp., Euro-BioImaging ERIC, FUJIFILM Holdings Corp., IVIM Technology Corp., Mediso Kft. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2019, Bruker collaborated to develop the first 18 Tesla, 11 cm bore, preclinical ultra-high field (UHF) MRI machine constantly.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global preclinical imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Advanced Molecular Vision, Inc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Aspect Imaging Ltd.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. AXT PTY LTD.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Preclinical Imaging Market by Product
    • 4.1.1. MicroCT (Micro Computed Tomography)
    • 4.1.2. MRI (Magnetic Resonance Imaging)
    • 4.1.3. PET (Positron Emission Tomography)
    • 4.1.4. Ultrasound Imaging
    • 4.1.5. Optical Imaging
    • 4.1.6. Photoacoustic Imaging
    • 4.1.7. Others ( Radiopharmaceuticals and Tracers, and Infrared Imaging )
  • 4.2. Global Preclinical Imaging Market by Application
    • 4.2.1. Research and Development
    • 4.2.2. Neurology and Neuroscience
    • 4.2.3. Others (Toxicology and Safety Assessment, Gene Therapy and Molecular Imaging, and Precision Medicine, and Personalized Therapies)
  • 4.3. Global Preclinical Imaging Market by End-User
    • 4.3.1. Pharma and Biotech Companies
    • 4.3.2. Academic and Research Institutions
    • 4.3.3. Hospitals and Medical Centers
    • 4.3.4. Government Research Agencies
    • 4.3.5. Others (Pharmacology and Toxicology Laboratories, and Regulatory Bodies & Authorities)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Bruker Corp.
  • 6.2. Euro-BioImaging ERIC
  • 6.3. FUJIFILM Holdings Corp.
  • 6.4. IVIM Technology Corp.
  • 6.5. Mediso Kft.
  • 6.6. MR Solutions Ltd.
  • 6.7. Oxford Nanoimaging Ltd.
  • 6.8. PerkinElmer AES
  • 6.9. Photon Etc. Inc
  • 6.10. Revvity, Inc.
  • 6.11. Shanghai United Imaging Healthcare Co., LTD.

LIST OF TABLES

  • 1. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MICROCT PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MRI PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PET PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ULTRASOUND PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL PHOTOACOUSTIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL OTHER PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
  • 10. GLOBAL PRECLINICAL IMAGING IN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PRECLINICAL IMAGING IN NEUROLOGY AND NEUROSCIENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL PRECLINICAL IMAGING IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRECLINICAL IMAGING FOR PHARMA AND BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PRECLINICAL IMAGING FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PRECLINICAL IMAGING FOR HOSPITALS AND MEDICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL PRECLINICAL IMAGING FOR GOVERNMENT RESEARCH AGENCIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL PRECLINICAL IMAGING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT , 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 24. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 27. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL MICROCT PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL MRI PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PET PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ULTRASOUND PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL PHOTOACOUSTIC PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL OTHERS PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL PRECLINICAL IMAGING IN RESEARCH AND DEVELOPMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL PRECLINICAL IMAGING IN NEUROLOGY AND NEUROSCIENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL PRECLINICAL IMAGING IN OTHERS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL PRECLINICAL IMAGING MARKET FOR ESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 14. GLOBAL PRECLINICAL IMAGING FOR PHARMA AND BIOTECH COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PRECLINICAL IMAGING FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PRECLINICAL IMAGING FOR NEUROLOGY AND NEUROSCIENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PRECLINICAL IMAGING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)